Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
[Dendritic cell-based therapeutic vaccination for acute myeloid leukemia]
Allogeneic partially HLA-matched dendritic cells (DC) as a vaccine in metastatic renal cell cancer (mRCC): Final analysis of a clinical phase I/II study.
Cancer therapy and vaccination
Cancer immunotherapy: a paradigm shift for prostate cancer treatment
Velogenic newcastle disease virus as an oncolytic virotherapeutics: in vitro characterization
Successful treatment of advanced ovarian cancer with thermochemotherapy and adjuvant immune therapy
Current status of immunological approaches for the treatment of prostate cancer
Hyperthermia-enhanced TRAIL- and mapatumumab-induced apoptotic death is mediated through mitochondria in human colon cancer cells
Co-culture of apoptotic breast cancer cells with immature dendritic cells: a novel approach for DC-based vaccination in breast cancer
Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
Construction of recombinant Newcastle disease virus Italien strain for oncolytic virotherapy of tumors
Hyperthermia induces cytoskeletal alterations and mitotic catastrophe in p53-deficient H1299 lung cancer cells
Pre-clinical assessment of autologous DC-based therapy in ovarian cancer patients with progressive disease
Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients
Cellular immunotherapy using dendritic cells against multiple myeloma
Re-irradiation plus regional hyperthermia for recurrent non-small cell lung cancer: a potential modality for inducing long-term survival in selected patients
The blockade of immune checkpoints in cancer immunotherapy
Cancer immunotherapy via dendritic cells
Extracellular vesicles–vehicles that spread cancer genes
Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial